Press Releases

Creative Enzymes Launches Raw Materials for Manufacturing Diagnostic Kits

Creative Enzymes Expands Its Probiotic Portfolio

Rising Prevalence of Isotope Labeling Carbohydrates Drives Innovations at BOC Sciences

BOC Sciences provides global customers with a range of high-quality stable isotope labeling compounds for biomedical research. It recently announced the availability of labeled carbohydrates, arousing an enthusiastic response from the market.

BOC Sciences: Peptides Open New Path toward Osteoporosis Treatment

BOC Sciences declares that some of its peptide products have been proven applicable for osteoporosis treatment, which is a significant contribution to the therapeutic areas.

BOC Sciences Makes Easy Access to Polymerization Tech

Owing to the continuously upgraded synthesis technologies and analytical abilities, BOC Sciences has performed well in the polymer industry, serving the community with a comprehensive product portfolio and valuable technical support.

BOC Sciences: ADC Analysis and Characterization Support Development, Registration, and Release

BOC Sciences announces support for antibody-drug conjugate (ADC) development, registration, and release by providing comprehensive analysis and characterization technologies.

Metatranscriptome Analysis Service Is Now Available at CD Genomics

Meet CD Genomics at the SITC 37th Annual Meeting

Expanded Offering of Fatty Amines for Diverse Applications

Creative Biogene Develops Custom Lentivirus Services to Support Stable Cell Line Generation

Microbiosci Releases LPS Extraction Service to Support Managing Endotoxins Issues

Creative Biogene Delivers Knockout Mouse Models to Support Gene Editing and Future Studies

Nanoparticle Development Services for Drug Delivery System Research

Acylation Reagents for Gas Chromatography and Other Instrumental Analytical Methods

ExoQuali Products and Protocols Released by Creative Bioarray to Easy Exosome Isolation Process

Histobiolab Provides Over 150 Fish Probes to Satisfy Precise Biological Research Needs

Creative Bioarray Provides 3D Cell Patterning Service Based to Speed up Drug Screening

Press Release: Terumo Pharmaceutical Solutions expands CDMO services outside Japan for global market

Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and infusion therapy devices, has today announced it will expand its contract development and manufacturing services for parenteral drugs to global customers.

Elligo Health Research® Named One of Central Texas’ Fastest-Growing Companies

Alfa Chemistry Announces Offering of Low Molecular Weight Carboxylic Acids